Type
1.
Blake I, Burton M, Bailey R, Solomon A, West S, Munoz B, et al. Estimating household and community transmission of ocular Chlamydia trachomatis. PLoS neglected tropical diseases [Internet]. 2009;3(3):e401. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655714/pdf/pntd.0000401.pdf
Type
1.
Blake I, Burton M, Solomon A, West S, Basáñez M-G, Gambhir M, et al. Targeting antibiotics to households for trachoma control. PLoS neglected tropical diseases [Internet]. 2010;4(11):e862. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970531/pdf/pntd.0000862.pdf
Type
1.
Broman AT, Shum K, Munoz B, Duncan D, West S. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Investigative ophthalmology & visual science. 2006;47(1):99-104.
Type
1.
Burton M, Hu V, Massae P, Burr S, Chevallier C, Afwamba I, et al. What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting. Investigative ophthalmology & visual science [Internet]. 2011;52(8):6012-7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176035/pdf/z7g6012.pdf
Type
1.
Cajas-Monson LC, Mkocha H, Munoz B, Quinn T, Gaydos C, West S. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania. PLoS neglected tropical diseases [Internet]. 2011;5(3):e978. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057946/pdf/pntd.0000978.pdf
Type
1.
Campbell P, Mkocha H, Munoz B, West S. Randomized trial of high dose azithromycin compared to standard dosing for children with severe trachoma in Tanzania. Ophthalmic epidemiology. 2009;16(3):175-80.
Type
1.
Campbell P, Mkocha H, Munoz B, West S. Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania. Ophthalmic epidemiology. 2012;19(1):38-42.
Type
1.
Courtright P, West S. Contribution of sex-linked biology and gender roles to disparities with trachoma. Emerging infectious diseases [Internet]. 2004;10(11):2012-6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328994/pdf/04-0353.pdf
Type
1.
Desmond N, Solomon A, Massae P, Lema N, Anemona A, Foster A, et al. Acceptability of azithromycin for the control of trachoma in Northern Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2005;99(9):656-63.
Type
1.
Frick K, Lynch M, West S, Munoz B, Mkocha H. Household willingness to pay for azithromycin treatment for trachoma control in the United Republic of Tanzania. Bulletin of the World Health Organization [Internet]. 2003;81(2):101-7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572402/pdf/12751418.pdf
Pagination
- Previous page
- Page 16
- Next page